Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Alexandrakis

Showing results (61-70 of 141) with videos related to

Pageof 15
Sort By:
American Journal of Clinical Oncology|January 22, 2002
Assaying of tumor necrosis factor alpha, complement factors, and alpha-1-antitrypsin in the diagnosis of malignant serous effusionsM G Alexandrakis, D Kyriakou, I E Koutroubakis, et al.
Retina (Philadelphia, Pa.)|February 24, 2001
Surgery for idiopathic macular holes associated with extensive subretinal fluidH Tabandeh, W E Smiddy, M Mello, et al.
Medical Oncology (Northwood, London, England)|April 15, 2014
Circulating levels of soluble Fas ligand reflect disease progression in multiple myelomaMichael G Alexandrakis, Constantina A Pappa, Anna Kolovou, et al.
Journal of Cancer Research and Clinical Oncology|June 8, 2014
Prognostic impact of angiopoietin-2 in multiple myelomaConstantina A Pappa, Michael G Alexandrakis, Anna Boula, et al.
Cancer Investigation|March 5, 2015
Mast cells influence the proliferation rate of myeloma plasma cellsConstantina A Pappa, George Tsirakis, Emilia Stavroulaki, et al.
Cancer Investigation|June 14, 2013
Serum levels of angiopoietin-2 are associated with the growth of multiple myelomaConstantina A Pappa, George Tsirakis, Panagiotis Samiotakis, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 9, 2002
Evaluation of bone disease in multiple myeloma: a correlation between biochemical markers of bone metabolism and other clinical parameters in untreated multiple myeloma patientsMichael G Alexandrakis, Freda H Passam, Niki Malliaraki, et al.
Hematological Oncology|February 28, 2003
Urinary N-telopeptide levels in multiple myeloma patients, correlation with Tc-99m-sestaMIBI scintigraphy and other biochemical markers of disease activityM G Alexandrakis, D S Kyriakou, F H Passam, et al.
Acta Gastro-Enterologica Belgica|December 15, 2020
Basket versus balloon extraction for choledocholithiasis: a single center prospective single-blind randomized studyK Ekmektzoglou, P Apostolopoulos, K Dimopoulos, et al.
Clinical Therapeutics|January 8, 2016
Correlation of Mast Cell Density With Angiogenic Cytokines in Patients With Active Multiple MyelomaRodanthi Vyzoukaki, George Tsirakis, Constantina A Pappa, et al.
Pageof 15

Showing results (61-70 of 141) with videos related to

Sort By:
Pageof 15
American Journal of Clinical Oncology|January 22, 2002
Assaying of tumor necrosis factor alpha, complement factors, and alpha-1-antitrypsin in the diagnosis of malignant serous effusionsM G Alexandrakis, D Kyriakou, I E Koutroubakis, et al.
Retina (Philadelphia, Pa.)|February 24, 2001
Surgery for idiopathic macular holes associated with extensive subretinal fluidH Tabandeh, W E Smiddy, M Mello, et al.
Medical Oncology (Northwood, London, England)|April 15, 2014
Circulating levels of soluble Fas ligand reflect disease progression in multiple myelomaMichael G Alexandrakis, Constantina A Pappa, Anna Kolovou, et al.
Journal of Cancer Research and Clinical Oncology|June 8, 2014
Prognostic impact of angiopoietin-2 in multiple myelomaConstantina A Pappa, Michael G Alexandrakis, Anna Boula, et al.
Cancer Investigation|March 5, 2015
Mast cells influence the proliferation rate of myeloma plasma cellsConstantina A Pappa, George Tsirakis, Emilia Stavroulaki, et al.
Cancer Investigation|June 14, 2013
Serum levels of angiopoietin-2 are associated with the growth of multiple myelomaConstantina A Pappa, George Tsirakis, Panagiotis Samiotakis, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 9, 2002
Evaluation of bone disease in multiple myeloma: a correlation between biochemical markers of bone metabolism and other clinical parameters in untreated multiple myeloma patientsMichael G Alexandrakis, Freda H Passam, Niki Malliaraki, et al.
Hematological Oncology|February 28, 2003
Urinary N-telopeptide levels in multiple myeloma patients, correlation with Tc-99m-sestaMIBI scintigraphy and other biochemical markers of disease activityM G Alexandrakis, D S Kyriakou, F H Passam, et al.
Acta Gastro-Enterologica Belgica|December 15, 2020
Basket versus balloon extraction for choledocholithiasis: a single center prospective single-blind randomized studyK Ekmektzoglou, P Apostolopoulos, K Dimopoulos, et al.
Clinical Therapeutics|January 8, 2016
Correlation of Mast Cell Density With Angiogenic Cytokines in Patients With Active Multiple MyelomaRodanthi Vyzoukaki, George Tsirakis, Constantina A Pappa, et al.
Pageof 15